VSee Health received an expected deficiency notification letter from Nasdaq related to the delayed filing of the quarterly report on Form 10-Q for fiscal 2025.
The notice indicated non-compliance with Nasdaq Listing Rule 5250(c)(1) due to the failure to timely file the quarterly report with the SEC.
The company has requested a hearing before a Nasdaq Listing Qualifications Panel to review the potential delisting decision.
Non-Compliance Notice
VSee Health is not in compliance with the Nasdaq Listing Rule due to the delayed filing of the Form 10-Q for June 30, 2025.
Potential Delisting
The company faces the risk of delisting its common stock and warrants from the Nasdaq Capital Market if compliance is not regained.
Recovery Steps
VSee Health aims to take necessary measures to regain compliance with Nasdaq's listing rules promptly.
- The notice does not immediately affect the listing or trading of VSee Health's stock or warrants on the Nasdaq Capital Market.
- The company intends to address the issue of late filings and aims to file the Form 10-Q as soon as practicable.
- VSee Health's reputation and investor confidence may be impacted by the non-compliance with filing requirements.
Despite the notice of deficiency, VSee Health is committed to rectifying the filing delay and regaining compliance with Nasdaq's listing rules.